Group 1 - The company is expected to achieve a profit of between 120 million to 150 million yuan, marking a turnaround from a loss in the same period last year [1] - The projected net profit attributable to the parent company, after deducting non-recurring gains and losses, is estimated to be between 13.5 million to 20 million yuan, representing a year-on-year growth of 280.09% to 463.09% [1] - The previous year's net profit attributable to the parent company was a loss of 191.9729 million yuan, with a net profit of 3.5518 million yuan after deducting non-recurring gains and losses [1] Group 2 - The main reason for the performance change is the company's stable business expansion and delivery of existing orders, leading to an increase in operating income compared to the same period last year [1] - The fair value change of strategic investments in AI listed companies had a tax-effected impact of 86 million yuan on the current net profit [2]

[Jiadu Technology Group Co., Ltd. 2025 Semi-Annual Performance Forecast](index=1&type=section&id=%E4%BD%B3%E9%83%BD%E7%A7%91%E6%8A%80%E9%9B%86%E5%9B%A2%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B82025%E5%B9%B4%E5%8D%8A%E5%B9%B4%E5%BA%A6%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E5%85%AC%E5%91%8A) [Current Period Performance Forecast](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%83%85%E5%86%B5) The company expects to achieve profitability in the first half of 2025, with net profit attributable to shareholders of the parent company estimated between RMB 120 million and RMB 150 million, and net profit after deducting non-recurring gains and losses between RMB 13.5 million and RMB 20 million, showing significant year-on-year growth 2025 Semi-Annual Performance Forecast | Indicator | Estimated Amount (RMB) | Year-on-Year Change | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders of the Parent Company | RMB 120 million to RMB 150 million | Turn losses into profits | | Net Profit Attributable to Shareholders of the Parent Company After Deducting Non-Recurring Gains and Losses | RMB 13.5 million to RMB 20 million | Growth of 280.09% to 463.09% | - This performance forecast data is unaudited by a certified public accountant[2](index=2&type=chunk) [Prior Period Performance Review](index=1&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8A%E5%B9%B4%E5%90%8C%E6%9C%9F%E7%BB%8F%E8%90%A5%E4%B8%9A%E7%BB%A9%E5%92%8C%E8%B4%A2%E5%8A%A1%E7%8A%B6%E5%86%B5) In the same period of 2024, the company incurred losses, with net profit attributable to shareholders of the parent company at RMB -191.9729 million and net profit after deducting non-recurring gains and losses at RMB 3.5518 million 2024 Semi-Annual Performance Data | Indicator | Amount (RMB) | | :--- | :--- | | Net Profit Attributable to Shareholders of the Parent Company | -191.9729 million RMB | | Net Profit Attributable to Shareholders of the Parent Company After Deducting Non-Recurring Gains and Losses | 3.5518 million RMB | | Earnings Per Share | -0.0900 RMB | [Analysis of Performance Changes](index=2&type=section&id=%E4%B8%89%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E5%8F%98%E5%8A%A8%E7%9A%84%E4%B8%BB%E8%A6%81%E5%8E%9F%E5%9B%A0) The current period's performance achieved a turnaround from losses to profits, primarily due to increased main business revenue from expansion and order delivery, and a non-recurring gain of RMB 86 million from fair value changes in a strategically invested AI listed company - Stable business expansion and smooth delivery of existing orders drove year-on-year growth in operating revenue, forming the basis for achieving profitability[4](index=4&type=chunk) - Significant contribution from non-recurring gains and losses: The fair value change of the company's strategically invested AI listed enterprise had a positive impact of **RMB 86 million** (after tax) on current period net profit[4](index=4&type=chunk) [Risk Warning](index=2&type=section&id=%E5%9B%9B%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) The company states that there are no significant uncertainties affecting the accuracy of this performance forecast - The company confirms there are no significant uncertainties affecting the accuracy of this performance forecast[5](index=5&type=chunk) [Other Explanations](index=2&type=section&id=%E4%BA%94%E3%80%81%E5%85%B6%E4%BB%96%E8%AF%B4%E6%98%8E%E4%BA%8B%E9%A1%B9) The company reminds investors that the disclosed data is preliminary and unaudited, and the final financial data will be subject to the 2025 semi-annual report, so investors should be aware of investment risks - This forecast data is preliminary and unaudited by a certified public accountant; the final accurate data will be subject to the company's officially disclosed 2025 semi-annual report[6](index=6&type=chunk)

Group 1 - The company, Jiadu Technology (600728), expects to achieve a net profit attributable to shareholders of the parent company ranging from 120 million to 150 million yuan for the first half of 2025, indicating a turnaround from a loss to profit compared to the same period last year [1] - The company anticipates a net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, to be between 13.5 million and 20 million yuan, representing a year-on-year growth of 280.09% to 463.09% [1]

Core Points - The company is holding its fifth extraordinary general meeting of shareholders on July 18, 2025, to discuss key proposals [1][2] - A significant agenda item is the proposal to appoint KPMG Hong Kong as the auditing firm for the issuance of H shares and listing on the Hong Kong Stock Exchange [3][4] Group 1 - The meeting will take place at the company's office in Guangzhou, with both on-site and online voting options available for shareholders [1][2] - Shareholders must register in advance to speak during the meeting, and the board is obligated to answer questions unless they involve company trade secrets [1][4] - The proposal to appoint KPMG Hong Kong is based on their extensive experience in overseas listings and their independence and professional capability [4][5] Group 2 - KPMG Hong Kong has been providing audit, tax, and consulting services since 1945 and is a member of a global organization [4] - The firm is registered as a public interest entity auditor and has not faced any significant issues in its audit quality checks over the past three years [5] - The audit fees will be determined based on the complexity and requirements of the audit, with the board authorized to negotiate these fees [7][8]

2025 年第五次临时股东会会议资料 2025 年 7 月 18 日 1 / 6 佳都科技集团股份有限公司 2025 年第五次临时股东会会议资料 佳都科技集团股份有限公司 佳都科技集团股份有限公司 2025 年第五次临时股东会会议资料 佳都科技集团股份有限公司 2025 年第五次临时股东会会议议程 现场会议时间：2025 年 7 月 18 日 14:30 网络投票时间： 交易系统投票平台投票时间 2025 年 7 月 18 日 9:15-9:25，9:30-11:30，13:00-15:00 互联网投票平台投票时间 2025 年 7 月 18 日 9:15-15:00 现场会议地点：广州市天河区新岑四路 2 号公司三楼会议室 参会人员：2025 年 7 月 11 日在册的全体股东，公司董事及高级管理人员 会议议程： 一、审议议案（请宣读人介绍重点内容，请参会股东参阅书面材料） | 序号 | 议案 | 页码 | | --- | --- | --- | | 1 | 关于聘请公司发行 H | 股股票并在香港联合交易所有限公司上市审计 4 | | | 机构的议案 | | 二、讨论议案，股东发言。 发言注意事项：股东要 ...

Group 1 - The Shanghai Intelligent Transportation Index (H50035) rose by 0.66% to 1722.24 points, with a trading volume of 7.249 billion yuan [1] - Over the past month, the index has increased by 0.09%, decreased by 2.10% over the last three months, and has risen by 2.03% year-to-date [1] - The index series reflects the performance of listed companies influenced by changes in economic and consumption structures during the urbanization process, focusing on themes such as intensive, intelligent, and green low-carbon development [1] Group 2 - The top ten holdings of the Shanghai Intelligent Transportation Index include SAIC Motor (10.32%), Huayu Automotive (9.49%), Aerospace Electronics (9.01%), Hongfa Technology (8.87%), and others [1] - The index is composed entirely of stocks listed on the Shanghai Stock Exchange, with industrial (30.40%), consumer discretionary (30.09%), information technology (27.24%), and communication services (12.27%) sectors represented [2] - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2]

证券代码：600728 证券简称：佳都科技 公告编号：2025-063 佳都科技集团股份有限公司 关于召开2025年第五次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东会类型和届次 2025年第五次临时股东会 (二) 股东会召集人：董事会 (三) 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结 合的方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间：2025 年 7 月 18 日 14 点 30 分 召开地点：广州市天河区新岑四路 2 号公司三楼会议室 (五) 网络投票的系统、起止日期和投票时间。 至2025 年 7 月 18 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过互联网 投票平台的投票时间为股东会召开当日的 9:15-15:00。 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 ...

Core Viewpoint - The company, Jiadu Technology, has announced the initiation of preparations for issuing H-shares and listing on the Hong Kong Stock Exchange to enhance its international competitiveness and brand image [1][2]. Financial Performance - In 2022, 2023, and 2024, Jiadu Technology reported revenues of 5.336 billion, 6.228 billion, and 7.949 billion respectively, indicating a growth of 27.64% from 2023 to 2024 [2][3]. - The net profit attributable to shareholders for the same years was -262 million, 39.5 million, and -115 million, showing a significant decline of 129.1% in 2024 compared to 2023 [2][3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -40.37 million in 2022, -33.56 million in 2023, and 23.51 million in 2024, indicating a recovery in 2024 [2][3]. - The net cash flow from operating activities improved from -188.86 million in 2022 to 180.43 million in 2024, reflecting a significant turnaround [2][3]. Strategic Initiatives - The board of directors has authorized the management to start the preparatory work for the H-share listing, which is part of the company's broader internationalization strategy [1][2]. - The company plans to discuss specific details of the H-share listing with relevant intermediaries, although no concrete details have been finalized yet [1]. Regulatory Considerations - The H-share listing is subject to approval from the board, shareholders, and regulatory bodies such as the China Securities Regulatory Commission and the Hong Kong Stock Exchange, indicating potential uncertainties in the process [2].

Group 1 - The core viewpoint of the article is that Jiadu Technology Group plans to issue H-shares and list on the Hong Kong Stock Exchange as part of its global strategy to enhance financing channels and expand its technology application market [2] - Jiadu Technology has previously contributed to the digital transformation of Hong Kong's subway system, enhancing operational efficiency and service quality through initiatives like the QR code payment service [2] - The company aims to improve its international visibility and align its governance with international standards, thereby strengthening its global competitiveness [2] Group 2 - The trend of A-share companies pursuing secondary listings in Hong Kong is supported by favorable policies and the attractiveness of Hong Kong as an international financial center [3] - The Hong Kong market offers a rich variety of financing tools and attracts international investors, which is beneficial for companies looking to expand their global brand image [3] - The supportive policies, continuous optimization of the Hong Kong stock market, and increasing attention from international investors towards Chinese enterprises create a favorable external environment for A-share companies to list in Hong Kong [3]

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]